CONNIE NELSON: Open Payments
NPI 1740829845 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,216 in 63 payments from 9 companies in 2025. Trend: 2023 $830 · 2024 $650 · 2025 $1,216
Food & beverage: $1,216
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $549 |
| Otsuka America Pharmaceutical, Inc. | 12 | $235 |
| Supernus Pharmaceuticals, Inc. | 8 | $170 |
| Medline Industries LP | 1 | $100 |
| Janssen Pharmaceuticals, Inc | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Alkermes, Inc. | 1 | $18 |
Products named: VRAYLAR, REXULTI, Qelbree, SPRAVATO, TRINTELLIX, CAPLYTA, ARISTADA, ABILIFY MAINTENA.
Industry payments across NE — which companies pay providers there.
